Abstract
Previously, we isolated a series of cell lines from a human diploid fibroblast lineage as a model for multistep tumorigenesis in humans. After passaging a single LT-transfected fibroblast clone, differently progressed cell lines were obtained, including immortalized, anchorage-independent and tumorigenic cell lines. In the present paper, we analysed the gene expression profiles of these model cell lines, and observed that expression of the CapG protein was lost in the tumorigenic cell line. To examine the possibility that loss of CapG protein expression was required for tumorigenic progression, we transfected CapG cDNA into the tumorigenic cell line and tested for tumor-forming ability in nude mice. Results showed that ectopic expression of CapG suppressed tumorigenicity, but not growth in soft agar or liquid medium. We also found that certain cancer cell lines including stomach cancer, lung cancer and melanoma had also lost CapG expression. One such cancer cell line AZ521 also became non-tumorigenic after the introduction of CapG cDNA. Moreover, we showed that CapG expression was repressed in small-cell lung cancer tissues. Together, our findings indicated that CapG is a new tumor suppressor gene involved in the tumorigenic progression of certain cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akagi T, Shishido T, Murata K, Hanafusa H . (2000). Proc Natl Acad Sci USA 97: 7290–7295.
Dabiri GA, Young CL, Rosenbloom J, Southwick FS . (1992). J Biol Chem 267: 16545–16552.
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al (2002). Nature 417: 949–954.
De Corte V, Van Impe K, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J et al. (2004). J Cell Sci 117: 5283–5292.
Hahn WC, Weinberg RA . (2002). Nat Rev Cancer 2: 331–341.
Lal A, Lash AE, Altschul SF, Velculescu V, Zhang L, McLendon RE et al. (1999). Cancer Res 59: 5403–5407.
Oka K, Tomonaga Y, Nakazawa T, Ge H-Y, Bengtsson U, Stanbridge EJ et al. (1999). Genes, Chromosome Cancer 26: 47–53.
Pellieux C, Desgeorges A, Pigeon CH, Chambaz C, Yin H, Hayoz D et al. (2003). J Biol Chem 278: 29136–29144.
Prendergast GC, Ziff EB . (1991). EMBO J 10: 757–766.
Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE . (2002). Nature 418: 934.
Rajogopalan H, Nowak MA, Vogelstein B, Lengauer C . (2003). Nat Rev Cancer 3: 695–701.
Sagawa N, Fujita H, Banno Y, Nozawa Y, Katoh H, Kuzumaki N . (2003). Br J Cancer 88: 606–612.
Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D . (2004). Cell Mol Life Sci 61: 2614–2623.
Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K et al. (1995). Cancer Res 55: 3228–3232.
Van Ginkel PR, Gee RL, Walker TM, Hu D-N, Heizmann CW, Polans AS . (1998). Biochim Biophys Acta 1448: 290–297.
Yu F-X, Johnston PA, Sudhof TC, Yin HL . (1990). Science 250: 1413–1415.
Acknowledgements
We thank Dr Akagi for providing the pCX4 retrovirus vector. SH is a recipient of a grant from the Charitable Trust Osaka Cancer Researcher-Fund.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Rights and permissions
About this article
Cite this article
Watari, A., Takaki, K., Higashiyama, S. et al. Suppression of tumorigenicity, but not anchorage independence, of human cancer cells by new candidate tumor suppressor gene CapG. Oncogene 25, 7373–7380 (2006). https://doi.org/10.1038/sj.onc.1209732
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209732
Keywords
This article is cited by
-
Super-enhancer-associated gene CAPG promotes AML progression
Communications Biology (2023)
-
CapG promoted nasopharyngeal carcinoma cell motility involving Rho motility pathway independent of ROCK
World Journal of Surgical Oncology (2022)
-
Macrophage Inhibitory Cytokine-1 Is Overexpressed in Malignant Melanoma and Is Associated with Tumorigenicity
Journal of Investigative Dermatology (2009)
-
Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity
BMC Cancer (2008)